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Respiratory bacterial infections are a major cause of worldwide morbidity and mortality in both developing and industrialised countries. Although antibiotics are often effective, this is not universally the case. Initial treatment is often empirical, being either of broad spectrum or targeted to an assumed pathogen. Ideally, the organism causing infection should be identified with accuracy as soon as possible, enabling specific treatment to be initiated. Conventional The development of molecular probes for specific DNA sequences of these organisms and the application of other molecular biological techniques offers an opportunity to obtain a more rapid and specific diagnosis in many bacterial infections. Furthermore, the techniques offer a unique opportunity to investigate the pathogenetic mechanisms in bacterial infection. With this knowledge we will be able to devise other therapeutic strategies as an alternative to antibiotic treatment.
The purpose of this article is to outline how advances in molecular biological techniques will change our understanding and management of respiratory bacterial infections. It will focus primarily on two areas: (1) the development of DNA probes for diagnosis; and (2) the application of mutagenesis studies to elucidate molecular mechanisms of microbial pathogenesis.
DNA probes in the diagnosis of respiratory bacterial infections
ROLE OF DNA PROBES IN DIAGNOSIS
For the reasons I have outlined, the development of a probe that is species specific would have immediate application in the diagnosis of pneumonia. Indeed, diagnostic kits using DNA probes that detect Mycoplasma pneumoniae and Legionella pneumophila are now commercially available and are both sensitive and specific."A The refinement of these probes and the development of similar probes to detect Chlamydia pneumoniae and mycobacteria are likely to follow and will have important and immediate application in the diagnosis of these infections.5
A similar problem, though not strictly bacterial, arises in the diagnosis of Pneumocystis carinii infection, which is difficult with conventional techniques. Recent studies have shown that the organism can be identified in tissue by in situ hybridisation as well as in secretions.67 The diagnosis of mycobacterial infection is often delayed because several weeks are required for in vitro cultivation. DNA probes for identifying mycobacteria will be a considerable improvement over current technology. Probes for distinguishing M tuberculosis rapidly from the "atypical" mycobacteria will have an important effect on the management of patients, particularly in the setting of AIDS.
When numbers of the organism are low, the relevant sequences can be amplified by the polymerase chain reaction before hybridisation with the relevant probe. culture. In addition, these techniques have the potential to improve the quality of the information obtained from sputum by allowing bacteria to be quantified more readily in a whole sputum specimen, whereas Gram staining and culture sample only a portion of the specimen.
The DNA from the whole sputum sample can be extracted, and unique sequences of DNA corresponding to pathogens can be quantified in this aqueous extract. Where numbers of organisms are small, the amount of potential DNA can be amplified by the polymerase chain reaction before molecular probes are used as mentioned above. Analysis with DNA probes overcomes the problem of overgrowth of some bacterial species on culture plates, a major problem in identifying more fastidious bacteria such as the pneumococcus, particularly when swarming bacteria are present. When invasive techniques such as lung biopsy are used, in situ hybridisation with probes will allow pathogens to be identified in tissue, thereby confirming that they are invasive organisms. 
Five oligonucleotides of 17 bases each were synthesised. These oligonucleotides corresponded to DNA sequences from five different parts of the P6 gene from the N terminus of the protein to the C terminus. The probes were radiolabelled and used to probe DNA from 40 different strains of H influenzae in Southern blot assays to determine whether any parts of the P6 gene were similar among strains. The DNA from these strains had been previously digested with restriction enzymes to yield fragments of DNA of defined sizes on the basis of the known sequence of the P6 gene. Three of the five oligonucleotides hybridised with fragments of DNA of identical size in all 40 strains.
After identifying three probes that hybridise with DNA of all strains of H influenzae, we determined whether these probes were specific for H influenzae. DNA was purified from various bacterial species and tested with the probes. They were highly specific for H influenzae, showing no hybridisation with various other bacterial species. These probes also hybridise with H influenzae DNA in whole bacterial colonies, making it unnecessary to purify DNA from strains to be tested. These probes therefore show promise as diagnostic reagents for H influenzae in sputum. A slightly different approach has been used by Terpstra et al,21 22 who used labelled DNA from the whole genome to probe sputum samples and effectively identified H influenzae in sputum.
It will be straightforward to use these methods to identify sequences that are unique to each of the bacterial species that cause pneumonia. We can then envisage that a secretion sample submitted to the laboratory will be rapidly analysed with probes that will detect the presence of the major respiratory bacterial pathogens. This idea is depicted diagrammatically in figure 1. As a result, the clinician will know the results of a sputum analysis with regard to the presence or absence of potential pathogens in a matter of hours, (the exact time depending on the indicators used to label the probes) rather than days as with conventional bacterial culturesor even weeks for organisms such as the mycobacteria. Studies of mechanisms of microbial pathogenesis Bacterial pathogens possess certain characteristics that give them the capacity to compete successfully with other bacteria, gain access to the host, avoid host defence mechanisms, and multiply within the host. Studies designed to identify and characterise the factors that allow respiratory bacterial pathogens to cause disease represent a critical initial step in understanding pathogenesis at the molecular level and will lead directly to the development of strategies of intervention in these infections in the form of new therapies and vaccines.
The application of modern molecular biological techniques to studies of bacteria is leading to new and important information in several ways. 23 
LI
Linker I many others. The major impact of these studies from a practical standpoint will be the identification of bacterial antigens that will induce protection from infection. These observations will guide vaccine development in an effort to prevent bacterial pneumonia in populations at risk.
Once the appropriate antigens for vaccines are developed, the design and production of the vaccines themselves will be facilitated by the application of recombinant DNA technology.38
Genes encoding vaccine antigens can be cloned and expressed in prokaryotic cells, eukaryotic cells (yeast), or mammalian cells. This approach has yet to be applied to bacterial antigens but it has been used for viruses. For instance, a widely used recombinant vaccine for hepatitis B is expressed in yeast. Alternatively, antigens can be inserted and delivered in viruses of low pathogenicity, such as vaccinia virus, resulting in a live recombinant vaccine that produces an immune response to the inserted antigen.
Conclusions
The recent extraordinary advances in molecular biological techniques is providing investigators with the tools to study molecular mechanisms of microbial pathogenesis. The application of these techniques to the study of respiratory bacterial pathogens will have a profound impact on these infections. This will be manifested primarily in the development of better methods for diagnosis and a more detailed understanding of mechanisms of pathogenesis, which will lead to vaccine development. In view of the importance of respiratory bacterial infections as a worldwide health problem, it is appropriate to continue to devote substantial resources to the problem.
